Ilpo Vattulainen

Ilpo Vattulainen

Auto-generated profile, based on publicly available information

Ilpo Vattulainen

Department of Physics, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
PSPaulo Cesar Telles de Souza
Paulo Cesar Telles de Souza
RARiccardo Alessandri
Riccardo Alessandri
JBJonathan Barnoud
Jonathan Barnoud
STSebastian Thallmair
Sebastian Thallmair
IFIgnacio Faustino
Ignacio Faustino
SMSiewert-Jan Marrink
Siewert-Jan Marrink

1 March 2021 in Cell
Verified
Journal Article
Open access
PCPlinio Casarotto
Plinio Casarotto
MGMykhailo Girych
Mykhailo Girych
SFSenem M. Fred
Senem M. Fred
VKVera Kovaleva
Vera Kovaleva
RMRafael Moliner
Rafael Moliner
ECEero Castren
Eero Castren
It is unclear how binding of antidepressant drugs to their targets gives rise to the clinical antidepressant effect. We discovered that the transmembrane domain of tyrosine kinase receptor 2 (TRKB), the brain-derived neurotrophic factor (BDNF) receptor that promotes neuronal plasticity and antidepressant responses, has a cholesterol-sensing function that mediates synaptic effects of cholesterol. We then found that both typical and fast-acting antidepressants directly bind to TRKB, thereby facilitating synaptic localization of TRKB and its activation by BDNF. Extensive computational approaches including atomistic molecular dynamics simulations revealed a binding site at the transmembrane region of TRKB dimers. Mutation of the TRKB antidepressant-binding motif impaired cellular, behavioral, and plasticity-promoting responses to antidepressants in vitro and in vivo. We suggest that binding to TRKB and allosteric facilitation of BDNF signaling is the common mechanism for antidepressant action, which may explain why typical antidepressants act slowly and how molecular effects of antidepressants are translated into clinical mood recovery.

5 June 2023 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
RMRafael Moliner
Rafael Moliner
MGMykhailo Girych
Mykhailo Girych
CBCecilia A. Brunello
Cecilia A. Brunello
VKVera Kovaleva
Vera Kovaleva
CBCaroline Biojone
Caroline Biojone
ECEero Castren
Eero Castren
Psychedelics produce fast and persistent antidepressant effects and induce neuroplasticity resembling the effects of clinically approved antidepressants. We recently reported that pharmacologically diverse antidepressants, including fluoxetine and ketamine, act by binding to TrkB, the receptor for BDNF. Here we show that lysergic acid diethylamide (LSD) and psilocin directly bind to TrkB with affinities 1,000-fold higher than those for other antidepressants, and that psychedelics and antidepressants bind to distinct but partially overlapping sites within the transmembrane domain of TrkB dimers. The effects of psychedelics on neurotrophic signaling, plasticity and antidepressant-like behavior in mice depend on TrkB binding and promotion of endogenous BDNF signaling but are independent of serotonin 2A receptor (5-HT2A) activation, whereas LSD-induced head twitching is dependent on 5-HT2A and independent of TrkB binding. Our data confirm TrkB as a common primary target for antidepressants and suggest that high-affinity TrkB positive allosteric modulators lacking 5-HT2A activity may retain the antidepressant potential of psychedelics without hallucinogenic effects.

1 February 2006 in Biophysical Journal
Verified
Journal Article
Closed access
MPMichael Patra
Michael Patra
ESEmppu Salonen
Emppu Salonen
ETEmma Terama
Emma Terama
IVIlpo Vattulainen
Ilpo Vattulainen
RFRoland Faller
Roland Faller
MKMikko Karttunen
Mikko Karttunen

1 June 2003 in Biophysical Journal
Verified
Journal Article
Closed access
MPM. Patra
M. Patra
MKMikko Karttunen
Mikko Karttunen
MHM.T. Hyvönen
M.T. Hyvönen
EFE. Falck
E. Falck
PLP. Lindqvist
P. Lindqvist
IVI. Vattulainen
I. Vattulainen

12 March 2019 in Chemical Reviews
Verified
Journal Article
Open access
GEGiray Enkavi
Giray Enkavi
MJMatti Javanainen
Matti Javanainen
WKWaldemar Kulig
Waldemar Kulig
TRTomasz Róg
Tomasz Róg
IVIlpo Vattulainen
Ilpo Vattulainen
Biological membranes are tricky to investigate. They are complex in terms of molecular composition and structure, functional over a wide range of time scales, and characterized by nonequilibrium conditions. Because of all of these features, simulations are a great technique to study biomembrane behavior. A significant part of the functional processes in biological membranes takes place at the molecular level; thus computer simulations are the method of choice to explore how their properties emerge from specific molecular features and how the interplay among the numerous molecules gives rise to function over spatial and time scales larger than the molecular ones. In this review, we focus on this broad theme. We discuss the current state-of-the-art of biomembrane simulations that, until now, have largely focused on a rather narrow picture of the complexity of the membranes. Given this, we also discuss the challenges that we should unravel in the foreseeable future. Numerous features such as the actin-cytoskeleton network, the glycocalyx network, and nonequilibrium transport under ATP-driven conditions have so far received very little attention; however, the potential of simulations to solve them would be exceptionally high. A major milestone for this research would be that one day we could say that computer simulations genuinely research biological membranes, not just lipid bilayers.